SPYRE THERAPEUTICS, INC. Current Assets
SPYRE THERAPEUTICS, INC. (SYRE) had Current Assets of $1.17 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $1.17B.
- 2026-03-31: Assets, Current $763.95M.
- 2025-12-31: Assets, Current $777.78M.
- 2025-09-30: Assets, Current $504.60M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $1.17B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $763.95M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $777.78M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $504.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $538.83M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $569.77M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $608.47M 10-K · filed 2026-02-19 |
| 2024-09-30 | $421.08M 10-Q/A · filed 2024-11-18 |
| 2024-06-30 | $435.74M 10-Q/A · filed 2024-11-18 |
| 2024-03-31 | $487.27M 10-Q/A · filed 2024-11-18 |
| 2023-12-31 | $341.53M 10-K · filed 2025-02-27 |
| 2023-09-30 | $205.95M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $239.89M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $44.38M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $62.26M 10-K/A · filed 2024-11-18 |
| 2022-09-30 | $82.22M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $96.65M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $72.60M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $98.89M 10-K · filed 2023-03-02 |
| 2021-09-30 | $117.51M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $134.37M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $151.41M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $149.79M 10-K · filed 2022-03-08 |
| 2020-09-30 | $144.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $161.87M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $54.27M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $74.50M 10-K · filed 2021-03-18 |
| 2019-09-30 | $92.63M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $109.94M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $126.82M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $76.67M 10-K · filed 2020-02-24 |
| 2018-09-30 | $70.38M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $78.89M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $48.84M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $54.99M 10-K · filed 2019-03-07 |
| 2017-09-30 | $59.52M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $66.20M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $60.30M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $66.42M 10-K · filed 2018-03-13 |
| 2016-09-30 | $71.68M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $76.91M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $35.20M 10-Q · filed 2016-05-19 |
| 2015-12-31 | $38.29M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |